EUVIMEDEUVIMED entdecken
Crossref

Nicotinamide adenine dinucleotide attenuates neuronal apoptosis in spinal cord ischemia-reperfusion injury via the activation of PI3K/AKT pathway

Song Xue, Yuange Li, Yin Zhang, Qiang Zhang, Sifei Yu, Lei Xie, Yu Liang

European Journal of Pharmacology · 2026

DOI: 10.1016/j.ejphar.2025.178463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Song Xue und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China; Shanghai …. Hauptthemen laut MEDLINE: Apoptosis, Proto-Oncogene Proteins c-akt, Reperfusion Injury, NAD. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord ischemia-reperfusion injury (SCIRI) leads to acute neurological deficits primarily driven by oxidative stress and apoptotic cell death. The potential of exogenous nicotinamide adenine dinucleotide (NAD+) to confer acute neuroprotection, as well as the underlying mechanisms, remains poorly understood. Network pharmacology analysis implicated the PI3K/AKT signaling pathway as a potential mediator of NAD+ effects. To investigate this, we assessed NAD+ in both in vivo (rodent SCIRI model; 75 mg/kg, intraperitoneal administration at reperfusion) and in vitro (oxygen-glucose deprivation/reperfusion, OGD/R; 32 μM) settings. Functional recovery was evaluated using the BBB locomotor rating scale, while histopathological changes, apoptosis (via TUNEL staining), oxidative stress markers (SOD, MDA, ROS), and key apoptotic proteins (Bcl-2/Bax, cleaved caspase-3) were analyzed alongside PI3K/AKT pathway activation. Pharmacological inhibition with LY294002 was employed to validate pathway involvement. Our results demonstrate that NAD+ significantly improved motor function recovery, attenuated histological damage, and reduced both apoptosis and oxidative stress following SCIRI. Consistent cytoprotection was observed in the OGD/R model with 32 μM NAD+. Mechanistically, NAD+ restored phosphorylation levels of PI3K and AKT and favorably modulated apoptotic regulators-effects partially reversed by LY294002, confirming the critical role of the PI3K/AKT axis. These findings provide mechanistic evidence that exogenous NAD+ exerts acute neuroprotection during the early reperfusion phase, mediated through PI3K/AKT pathway activation and subsequent suppression of oxidative stress and apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisProto-Oncogene Proteins c-aktReperfusion InjuryNADPhosphatidylinositol 3-KinasesNeuronsSpinal Cord IschemiaNeuroprotective AgentsAnimalsSignal TransductionMaleOxidative StressRatsSpinal CordRats, Sprague-Dawley

Stichwörter der Autor:innen

ApoptosisNetwork pharmacologyNicotinamide adenine dinucleotidePI3K/AKT signaling pathwaySpinal cord ischemia-reperfusion injury

Substanzen

Proto-Oncogene Proteins c-aktNADPhosphatidylinositol 3-KinasesNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Orthopedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China; Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases…
  • Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
  • Department of Orthopedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China.
  • Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China.
  • Department of Orthopedic Surgery, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.

Förderung

  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Xue, S., Li, Y., Zhang, Y., Zhang, Q., Yu, S., Xie, L., & Liang, Y. (2026). Nicotinamide adenine dinucleotide attenuates neuronal apoptosis in spinal cord ischemia-reperfusion injury via the activation of PI3K/AKT pathway. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178463

Vancouver

Xue S, Li Y, Zhang Y, Zhang Q, Yu S, Xie L, et al. Nicotinamide adenine dinucleotide attenuates neuronal apoptosis in spinal cord ischemia-reperfusion injury via the activation of PI3K/AKT pathway. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2025.178463

BibTeX
@article{Xue2026,
  author = {Xue, Song and Li, Yuange and Zhang, Yin and Zhang, Qiang and Yu, Sifei and Xie, Lei and Liang, Yu},
  title = {Nicotinamide adenine dinucleotide attenuates neuronal apoptosis in spinal cord ischemia-reperfusion injury via the activation of PI3K/AKT pathway},
  journal = {European Journal of Pharmacology},
  year = {2026},
  doi = {10.1016/j.ejphar.2025.178463}
}
Kostenlos starten →